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~ ' ~  Yttrium-90, a New Emitter for  Prevention of Beta 
Post Angioplasty Re~enosis: "iissue Oosimetry and 
Importance of Intmarterlal Centering 
Vitali Verin, Youd Popewsld, Philip Urban, Phillip Nouet, Michel Rouzaud, 
Michael Schwager, John M, Kurtz, Wilhelm Rutishauser. University 
Hospital, Geneva, Switzerland 
Intraarterial irradiation reduces restenosis following experimental balloon 
angioplasty. Beta irradiation has the advantages of a markedly steeper dose 
decrease in tissue and less radiopmteetian problems, allowing its use in 
an ordinary catheterization laboratory. We developed a dedicated 90-Yttrium 
(SOy) pure beta-emifting source, in the form of a flexible coil (diameter 0.014", 
length 22 ram) attached to the distal end of a 0.014" thrust wire. A segmented 
balloon consisting of four interconnected compartments (Schneider-Europe, 
AG) was developed to allow for intraartedal centering of the soY source. The 
tissue depth curve and dose vadabilify on the surface of 1) conventional 
angioplasty balloons and 2) the centering balloon were studied using small 
thermoluminas(ent dosimeters. The tissue-0epth dose curve for standard 
2.5, 3, 3.5 and 4 mm balloons filled with contrast medium (Omnipaque 240) 
normalized to a surface dose of 10 Gy is presented in the figure. The standard 
deviations (percents of the mean) for the surface doses of 2.5, 3, 3.5, and 
4 mm conventional PTCA balloons were 1.9 (13",.), 5.5 (59%), 5.8 (73%), 
and 6.5 (110%) Gy. respectively. The mean, minimum and maximum doses 
on the surface of the 3.5 mm centering balloon were 8.4, 7.3, and 9.5 Gy 
(standard eviation 0.66 Gy, or 8% of the mean). 
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Conclusions: 1) The tissue dose distribution of SOy is well suited to the 
purpose of selective irradiation of the coronary arterial wall (thickness 0.3- 
0.8 mm)-for prevention of restenosis; 2) Homogeneous intramural dose 
delivery can be acheived with the help of a specially designed centering 
balloon. 
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[ -~"~ Imaging of Human Atheresclerotic LeMons With 
In-111 7.203 Antibody Specific for  Proliferating 
Smooth Muscle Cells in Human Atheroma 
Pleduigi Pied, Ignasi Carrib, Jagat Narula, Giovanni Moscatelli, 
Lourdes Pret, Luclano Peddni, vi(ens Riambau, Chds Pak, Francis Chan, 
Ban-An Khaw. Bufalini Hospital, Cesena, Italy; Hospital de Sent Pau, 
Barcelona, Spain: S(etgen, Menlo Park, CA; Northeastern Univer#l~, 
Boston, MA 
Radiolabeled mouse/human chlmedo antibody Z2D3 specific for an antigen 
on proliferating smooth muscle cells in human atberema has been used to 
noninvasively visualize experimental theresclerotic lesions In rabbits. Fur- 
thermore, negative-charge polymer-modification f Z2D3 allowed enhanced 
target visualization with very high specific radioactivity and reduced back- 
ground activity. 
To evaluate its usefulness, negative charge-modified Z2D3 F (ab')2 was 
administered to 11 patients undergoing carotid endarferectomy. Each patient 
received 250 pg of Z2D3 labeled with 5 mCi of In-111 i.v. Sedal gamma 
images, blood and urine samples were obtained for 72 H following injection. 
Carotid endarterectomy was performed within 48 H after the last imaging 
session. The sites of stenosis seen arteriographically were compared to 
location of the most intense antibody uptake. Endarterectomy specimens 
were imaged ex-vlvo and then characterized immunohiatechamically, 
The Concentration of the antibody was seen in all patients in the region of 
the carotid plaques. Uptake was focal and was best seen at 4 H. Intensity of 
uptake decreased over time, Whole body scans demonstrated localization i  
the kidneys, liver, and bone marrow which remained essentially unchanged. 
No adverse reactions to the antil~xly were observed. Immunohistochemistry 
of endarterectomy specimens demonstrated specific localization of Z2D3 in 
the region of proliferating smooth muscle cells in the intima of the lesion. 
The present study demonstrated the feasibility of noninvasive visualization 
of human atherosclemtic lesions. Further studies will be needed to optimize 
the imaging technique for potential clinical applications. 
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~What  Causes Focal Reetenosis at the Margins of 
Palmaz-Schalz stems? A Serial Intravascular 
UIImseund Study 
Ratner Hoffman, Gary S. Mintz, Jeffrey J. Popma, Augusto D. Pichard, 
Lowell R Sailer, Kenneth M. Kent, Jennifer Griffin, Theresa Bucher, 
Roif Fuessl, Mary K. Kehoe, Donna Hunn, Debra Detorty, Martin B. Leon. 
Washington Hospital Center, Washington, DC 
To understand the mechanism of restenosis atthe margins of Palmaz-Schatz 
stents, we compared sedal intrevascular uifra;ound (NUS) studies post stent 
implantation and follow-up (5 4 4. 3.8 months) in 88 lesions and analyzed 
reference {Ref: artedal, lumen, and plaque areas (in ram2); plaque burden 
(plaque/arterial res); remodeling (z$ artenal area); tissue growth (~, plaque 
area); and dissections} and stent margin {slant and intimel hyperplasia (IH) 
areas}. 29 lesions had focal restenosis involving one or both margins. 
Restenosis No Restenosis p 
Post-steal Ref arleflal area 15.8 -;- 3.8 18.6 4- 7.5 0.1097 
lumen area 8.5 4- 3A 10.8 -;- 5.3 0.0686 
plaque burden 48 4-13 43 4-12 0.0868 
Ref remodeling 2.2 4-1,8 1.2  4-  2.4 0.0692 
Slant area 8.7 4- 3.6 10.44- 4.4 0.0607 
IH area w~hin sterd 5.04- 2.7 2.1 4-1.8 < 0.0001 
Stent margin dissections were uncommon (4/88). There was no significant 
tissue growth (6 plaque area) at the Ref sites or recoil (A stent area) of the 
stent margins. Weconclude:Restenosis atthe stent margin is common (3,.~.0) 
and is associated with implanting the edge of the stent within smaller, more 
diseased Ref vessels (smaller artenal, lumen, and stont areas; greater plaque 
burden). Superimposed Ret segment remodeling and neointimal tissue ac- 
cumulation within smaller stant margins results in restenosis. These findings 
undedie the importance of anchoring edges of Palmaz-Schatz stants into 
healthy vessels with large lumens; this may require more extensive slanting 
to cover moderate proximal or distal stenesas. 
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~"~-~ An Open Multicanter Registry to Evaluate Local 
Hepadn Delivery Following Balloon Angioplasty for  
the Prevention of Restenosis: Preliminary Results 
Edeardo Camanzlnd, Victor Legrand. Mathias Vrolix. Clat,'de Hanet. 
William Wijns, Christophe Bauters. Wire Aengevaeren, Peter den Heijer, 
Tony Gershlick, Eline Montauban van Swijndregt, Peter van tier Meer, 
Rein MelkerL Patrick Serruys, on behalf of the DISPATCH Investigators. 
Thorax(enter, Erasmus Universi~, Rotterdam, The Nether~ands 
Although heparin has been shown effective to prevent restenosls in ani- 
mal studies, previous clinical studies have failed to show any efficacy after 
systemic administration. 
Local, int~acomnmy hoparin delivery (Dispatch" Sdmed; 1783 4. 185 IU 
dudng 30 4- 3 min) was successfully performed in 117 patients (79 men, 
62 4. 10 years) following balloon angioplasty. No acute cardiac event were 
observed udng hospital stay. Meanwhife 43 patients (32 men, 58 4. 9 yeats) 
have been reviewed clinically and angiographically for 6 month foUow-up: 10 
patients were symptomatic (3 unstable and 7 stable angina). Angingraphy 
showed In 10143 (23%) restenosis (diameter stanests > 58%). No aneurys- 
matic dilatation at the site of hepadn dalivanj was observed. MLD measured 
by quantitative analysis ystem (CAAS II) in matched projections changed 
from 1.15 4- 0.36 mm (pre) through 2.03 4- 0,44 mm (post) to 1.75 4- 0.62 
mm (at 6 month follow-up). 
LOcal '~ogarin Matched group" to-value 
Acute gain (ram) 0.90 4- 0.46 0.go ± 0.46 NS 
Late loss (ram) 0.28 ± 0.58 0.45:1:0.58 <0.05 
*matched for vessel size, acute gain and lesion location 
Nine patients (21%) required a re-PTCA and f patient required surgery 
(2%) of the treated segment. No myocardial infarction and no death were 
observed. 
Conclusion: Local hapmin delivery following balloon angioplaaty by means 
of the coil-balloon may reduce on Iongterm the incidence of restanosis and 
decrease the need for re-vascutarization. 
